Open access
Sep 2026
γδ T cells modulate anti-tumor immunity in small cell lung cancer.
Small cell lung cancer (SCLC) is a highly aggressive neoplasm with limited sensitivity to anti-PD-(L)1 blockade, which is likely caused by the epigenetic silencing of MHC-I. Elucidating MHC-I-independent immune recognition mechanisms is therefore crucial for enhancing treatment responses and improving clinical outcomes...
Jin Ng, Yue You, Tina Zhang et al.
· Cancer Cell · 0 citations